Vaginal atrophy drug Ospemifene found effective in breast cancer Prevention
Study results from two research papers have shown that use of the drug Ospemifene in combination with other anti-estrogens for vaginal atrophy reduces the incidence of breast cancer. // The study has been proved in mouse model and researchers are planning for a clinical trial. DeGregorio and ...QUATRX PHARMACEUTICALS ADVANCES U.S. CLINICAL TRIALS FOR FISPEMIFENE ...
Ospemifene Phase III Dosing Commences ... Ospemifene is a selective estrogen receptor modulator, or SERM, an orally available ...METHODS FOR THE PREPARATION OF FISPEMIFENE FROM OSPEMIFENE - Patent
Ospemifene has relatively weak estrogenic and antiestrogenic effects in the ... Ospemifene is also the first SERM (selective estrogen receptor modulator) which ...